Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: - | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Eye irritation
Administrative data
- Endpoint:
- eye irritation: in vitro / ex vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 29 June 2020
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 020
- Report date:
- 2020
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 438 (Isolated Chicken Eye Test Method for Identifying i) Chemicals Inducing Serious Eye Damage and ii) Chemicals Not Requiring Classification for Eye Irritation or Serious Eye Damage)
- Version / remarks:
- 25 June 2018
- Deviations:
- no
- Principles of method if other than guideline:
- On request of the sponsor, an additional classification is made with the scheme of Schutte et al (2009), Regulatory Toxicology and Pharmacology 54.
- GLP compliance:
- yes (incl. QA statement)
- Remarks:
- d.d. 03 August 2018
Test material
- Reference substance name:
- [2,2-bis[(3,7-dimethyl-2,6-octadienyl)oxy]ethyl]benzene
- EC Number:
- 266-805-6
- EC Name:
- [2,2-bis[(3,7-dimethyl-2,6-octadienyl)oxy]ethyl]benzene
- Cas Number:
- 67634-02-0
- Molecular formula:
- C28H42O2
- IUPAC Name:
- (2,2‐bis(((E)‐3,7‐dimethylocta‐2,6‐dien‐1‐yl)oxy)ethyl)benzene
- Test material form:
- liquid
1
Test animals / tissue source
- Species:
- chicken
- Strain:
- other: ROSS 308
- Details on test animals or tissues and environmental conditions:
- SOURCE OF COLLECTED EYES
- Source: TARAVIS KFT. (Address: H-9600 Sárvár, Rábasömjéni utca 129., Hungary)
- Storage, temperature, and transport conditions of ocular tissue: Chicken heads (7 weeks old) were collected and transported to the test site at ambient temperature at the earliest convenience. The heads were received at test site and were processed within 2 hours of collection.
Test system
- Vehicle:
- unchanged (no vehicle)
- Controls:
- yes, concurrent positive control
- yes, concurrent negative control
- Amount / concentration applied:
- TEST MATERIAL
- Amount applied: 30 µL per cornea.
POSITIVE CONTROL
- Amount applied: 30 µL per cornea.
- This material was mixed with distilled water to achieve the final concentration of 5% (w/v). The treatment solution was prepared immediately before the experiment.
NEGATIVE CONTROL
- Amount applied: 30 µL per cornea. - Duration of treatment / exposure:
- 10 seconds
- Duration of post- treatment incubation (in vitro):
- 240 minutes
- Number of animals or in vitro replicates:
- 3 replicates for the positive and treatment group each and one for the negative group
- Details on study design:
- SELECTION AND PREPARATION OF ISOLATED EYES
The eyeball was carefully removed from the orbit by holding the nictitating membrane with a surgical forceps, while cutting the eye muscles with bent scissors. Care was taken to remove the eyeball from the orbit without cutting off the optical nerve too short. The procedure avoided pressure on the eye while removing the eyeball from the orbit, in order to prevent distortion of the cornea and subsequent corneal opacity. Once removed from the orbit, the eye was placed onto damp paper and the nictitating membrane was cut away with other connective tissue. The prepared eyes were kept on the wet papers in a closed box so that the appropriate humidity was maintained.
Eyes were examined with slit lamp microscope to ensure that they were in good condition. The focus was adjusted to see clearly the physiological saline which was flowing on the cornea surface. Eyes with a high baseline fluorescein staining (i.e., > 0.5) or corneal opacity score (i.e., > 0.5) were rejected. The cornea thickness was measured, any eye with cornea thickness deviating more than 10 % from the mean value for all eyes, or eyes that showed any other signs of damage, were rejected and replaced. If the selected eyes were appropriate for the test, acclimatization started and it was conducted for approximately 45 to 60 minutes. The chambers of the superfusion apparatus were at controlled temperature (32±1.5°C) during the acclimatization and treatment periods.
EQUILIBRATION AND BASELINE RECORDINGS
At the end of the acclimatization period, a zero reference measurement was recorded for cornea thickness and opacity to serve as a baseline (t=0) for each individual eye. The cornea thickness of the eyes should not change by more than 5% within the -45 min and the zero time. No significant corneal thickness changes (-1.6% was observed in one eye) and no corneal thickness changes were observed in the other eyes. Following the equilibration period, the fluorescein retention was measured. Baseline values were required to evaluate any potential test item related effect after treatment. All eyes were considered to be suitable for the assay
ADMINISTRATION OF TEST AND CONTROL ITEMS
After the zero reference measurements, the eye in its retainer was taken out of the chamber and placed on a layer of tissue with the cornea facing upwards. The eye was held in horizontal position, while the test material was applied onto the centre of the cornea. 30 μL of the test item was applied onto the entire surface of the cornea attempting to cover the cornea surface uniformly with the test item, taking care not to damage or touch the cornea. The positive and negative control eyes were treated in a similar way.
REMOVAL OF TEST SUBSTANCE
After an exposure period of 10 seconds the cornea surface was rinsed thoroughly with 20 mL physiological saline solution at ambient temperature to remove all residual test material without damaging the eyes. The solubility of the test item in physiological saline was tested prior to the experiment, the test item did not dissolve in physiological saline.
OBSERVATION PERIOD
-Corneal thickness and corneal opacity: Pre- treatment and at approximately (±5 minutes) 30, 75, 120, 180 and 240 minutes after the post-treatment rinse
-Fluorescein retention: Pre- treatment and at approximately (±5 minutes) 30 minutes after the post-treatment rinse
METHODS FOR MEASURED ENDPOINTS:
- Corneal swelling: An optical pachymeter on a slit lamp microscope
- Corneal opacity: slit lamp microscope
- Fluorescein retention: slit lamp microscope
SCORING SYSTEM:
- Mean corneal swelling (%):
corneal swelling (t) = (cornea thickness (t) – cornea thickness at t=0) / (cornea thickness at t=0) x 100
Mean corneal swelling (t) = (1st eye corneal swelling (t)+ 2nd eye corneal swelling (t) +3rd eye corneal swelling (t)) /3
For the calculation of maximum corneal swelling, small negative numbers for swelling following application (0 to -5%) are counted as zero (scored as class I). Large negative numbers (>12% below control) are probably due to erosion and indicate a severe effect (scored as class IV). Cases of values of -5% to -12% are evaluated on a case by case basis but in the absence of other findings do not indicate a severe effect (class II).
- Mean maximum opacity score:
Δcornea opacity (t) = cornea opacity (t) – cornea opacity at t=0
Mean Δcornea opacity (max) = 1st eye cornea opacity max(30min to 240min)+ 2nd cornea opacity eye max(30min to 240min) + 3rd eye cornea opacity max(30min to 240min) /3
- Mean fluorescein retention score at 30 minutes post-treatment:
Δfluorescein retention(t) = fluorescein retention (t) – fluorescein retention at t=0
Mean Δfluorescein retention = (1st eye fluorescein retention (30min) + 2nd eye fluorescein retention (30min) + 3rd eye fluorescein retention (30min)) /3
DECISION CRITERIA: The mean maximum corneal swelling up to 75 or 240 min, the mean maximum corneal opacity and the mean fluorescein retention change were assinged ICE classes which are used for classification according to UN GHS (2018) criteria or Schutte et al (2009) criteria. (see Tables 1 t/m 7)
Results and discussion
In vitro
Resultsopen allclose all
- Irritation parameter:
- other: Mean maximum corneal swelling at up to 75 min
- Run / experiment:
- Mean of 3 replicates (%)
- Value:
- 1.7
- Vehicle controls validity:
- not applicable
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Remarks:
- Mean corneal swelling: 8.7%
- Remarks on result:
- other: ICE CLASS I
- Irritation parameter:
- other: Mean maximum corneal swelling at up to 240 min
- Run / experiment:
- Mean of 3 replicates (%)
- Value:
- 1.1
- Vehicle controls validity:
- not applicable
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Remarks:
- Mean corneal swelling: 20.7%
- Remarks on result:
- other: ICE CLASS I
- Irritation parameter:
- other: Mean maximum corneal opacity change
- Run / experiment:
- Mean of 3 replicates
- Value:
- 0.17
- Vehicle controls validity:
- not applicable
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Remarks:
- Cornea Opacity: 4.00
- Remarks on result:
- other: ICE CLASS I
- Irritation parameter:
- other: Mean fluorescein retention change
- Run / experiment:
- Mean of 3 replicates
- Value:
- 0.33
- Vehicle controls validity:
- not applicable
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Remarks:
- Fluorescein retention: 3.00
- Remarks on result:
- other: ICE CLASS I
- Other effects / acceptance of results:
- For detailed results see "attached full study report".
See table 8 and 9 for interpretation of the obtained results according to the UN GHS classification scheme and the scheme of Schutte et al (2009), Regulatory Toxicology and Pharmacology 54.
ACCEPTANCE OF RESULTS:
The results from all eyes used met the quality control standards. The negative control and positive control results were within the historical data range. This study was considered to be valid.
Any other information on results incl. tables
Table 8. SUMMARY TABLE FOR UN GHS CLASSIFICATION
Criteria for “No category” (all true) |
|
3 endpoints classed as I or 2 endpoints classed as I and 1 endpoint classed as II or 1 endpoint classed as I and 2 endpoints classed as II: |
True |
No severe corneal morphological changes: |
True |
Test item was not stuck to the cornea at 240 minutes after the posttreatment rinse: |
True |
Criteria for “Category 1” (one or more true) |
|
2 or more endpoints classed as IV: |
False |
Corneal opacity ≥ 3 at 30 min (in at least 2 eyes): |
False |
Corneal opacity = 4 at any time point (in at least 2 eyes): |
False |
Severe loosening of epithelium (in at least 1 eye): |
False |
Criteria for “No prediction can be made” (one or two true) |
|
Based on the endpoints not classifiable for No Category, or for Category 1: |
False |
Particles of test item were stuck to the cornea and could not be washed off during the study: |
False |
Table 9. SUMMARY TABLE FOR SCHUTTE et al (2009) CLASSIFICATION
Criteria for “Not irritating” (all true) |
|
3 endpoints classed as I or 2 endpoints classed as I and 1 endpoint classed as II |
True |
No severe corneal morphological changes: |
True |
Test item was not stuck to the cornea at 240 minutes after the posttreatment rinse: |
True |
Criteria for “Severely irritating”, corresponding to UN GHS Category 1 (one or more true) |
|
2 or more endpoints classed as IV: |
False |
Corneal opacity ≥ 3 at 30 min (in at least 2 eyes): |
False |
Corneal opacity = 4 at any time point (in at least 2 eyes): |
False |
Severe loosening of epithelium (in at least 1 eye): |
False |
Criteria for “Slightly irritating”, corresponding to UN GHS Category 2B (both true) |
|
Not meeting the criteria for “Not irritating”, or for Category 1: |
False |
3 endpoints classed as II or 2 endpoints classed as II and 1 endpoint classed as I or 1 endpoint classed as I and 1 endpoint classed as II and 1 endpoint classed as III or 2 endpoints classed as II and 1 endpoint classed as III or 2 endpoints classed as I and 1 endpoint classed as IV. |
False |
Criteria for “Moderately irritating”, corresponding to UN GHS Category 2A (both true) |
|
Not meeting the criteria for “Not irritating”, or for Category 1: |
False |
3 endpoints classed as III or 2 endpoints classed as III and 1 endpoint classed as II or 2 endpoints classed as III and 1 endpoint classed as IV or 2 endpoints classed as III and 1 endpoint classed as I or 2 endpoints classed as II and 1 endpoint classed as IV or 1 endpoint classed as II and 1 endpoint classed as III and 1 endpoint classed as IV. |
False |
Applicant's summary and conclusion
- Interpretation of results:
- other: No an eye irritant in accordance with EU CLP (EC no 1272/2008 and its amendments)
- Conclusions:
- The substance is not an eye irritant in the Isolated Chicken Eye Test (OECD guideline 438).
- Executive summary:
An Isolated Chicken Eye Test (ICET) was performed with the Substance according to OECD guideline 438 and in accordance with GLP principles. Thirty µL of the Substance was applied to corneas (n=3). After 10 seconds exposure time, the surface of the eyes was rinsed with physiological saline solution. No significant corneal swelling change (mean = 1.1%) was observed during the four-hour observation period on test item treated eyes. No significant cornea opacity change (severity 0.5 on one eye and no cornea opacity change on two eyes) was observed. No significant fluorescein retention change (severity 0.5 on two eyes and no fluorescein retention change on one eye) was noted. No other morphological effect was observed. The negative control and positive control results were within the historical data range. It was therefore concluded that the test conditions were adequate and that the test system functioned properly. Based on the results, the endpoints Corneal swelling, Corneal opacity and Fluorescein retention were assigned ICE CLASS I and the substance is therefore not irritating to eyes.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.